EP0429458A4 - Method of inducing lysine overproduction in plants - Google Patents
Method of inducing lysine overproduction in plantsInfo
- Publication number
- EP0429458A4 EP0429458A4 EP19890905254 EP89905254A EP0429458A4 EP 0429458 A4 EP0429458 A4 EP 0429458A4 EP 19890905254 EP19890905254 EP 19890905254 EP 89905254 A EP89905254 A EP 89905254A EP 0429458 A4 EP0429458 A4 EP 0429458A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- gene
- plant
- lysine
- dhdps
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004472 Lysine Substances 0.000 title claims description 93
- 238000000034 method Methods 0.000 title claims description 45
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 title description 76
- 238000012261 overproduction Methods 0.000 title description 6
- 230000001939 inductive effect Effects 0.000 title description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 145
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 113
- 210000004027 cell Anatomy 0.000 claims description 89
- 108091000044 4-hydroxy-tetrahydrodipicolinate synthase Proteins 0.000 claims description 71
- 239000013612 plasmid Substances 0.000 claims description 51
- 230000014509 gene expression Effects 0.000 claims description 34
- 210000001519 tissue Anatomy 0.000 claims description 29
- 241000588724 Escherichia coli Species 0.000 claims description 26
- 108010031100 chloroplast transit peptides Proteins 0.000 claims description 24
- 210000003763 chloroplast Anatomy 0.000 claims description 23
- 230000001580 bacterial effect Effects 0.000 claims description 22
- 230000009466 transformation Effects 0.000 claims description 22
- 235000019766 L-Lysine Nutrition 0.000 claims description 17
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 17
- 230000005764 inhibitory process Effects 0.000 claims description 17
- 230000002103 transcriptional effect Effects 0.000 claims description 16
- 230000001105 regulatory effect Effects 0.000 claims description 11
- 230000010076 replication Effects 0.000 claims description 10
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims description 9
- 108010077805 Bacterial Proteins Proteins 0.000 claims description 9
- 241000894007 species Species 0.000 claims description 9
- 230000001965 increasing effect Effects 0.000 claims description 6
- 230000001404 mediated effect Effects 0.000 claims description 6
- 238000004520 electroporation Methods 0.000 claims description 5
- 230000006696 biosynthetic metabolic pathway Effects 0.000 claims description 4
- 239000013599 cloning vector Substances 0.000 claims description 4
- 238000000520 microinjection Methods 0.000 claims description 3
- 238000005538 encapsulation Methods 0.000 claims description 2
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 description 151
- 229960003646 lysine Drugs 0.000 description 87
- 235000018977 lysine Nutrition 0.000 description 75
- 239000012634 fragment Substances 0.000 description 51
- 108020004414 DNA Proteins 0.000 description 33
- UWOCFOFVIBZJGH-YFKPBYRVSA-N (S)-2,3-dihydrodipicolinic acid Chemical compound OC(=O)[C@@H]1CC=CC(C(O)=O)=N1 UWOCFOFVIBZJGH-YFKPBYRVSA-N 0.000 description 26
- 108090000765 processed proteins & peptides Proteins 0.000 description 24
- 108091026890 Coding region Proteins 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 150000001413 amino acids Chemical class 0.000 description 15
- 238000000338 in vitro Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 241000589158 Agrobacterium Species 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 12
- 239000003550 marker Substances 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 244000061176 Nicotiana tabacum Species 0.000 description 11
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 11
- 229940024606 amino acid Drugs 0.000 description 11
- 238000010276 construction Methods 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 229930027917 kanamycin Natural products 0.000 description 10
- 229960000318 kanamycin Drugs 0.000 description 10
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 10
- 229930182823 kanamycin A Natural products 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 108020004999 messenger RNA Proteins 0.000 description 9
- 239000002773 nucleotide Substances 0.000 description 9
- 125000003729 nucleotide group Chemical group 0.000 description 9
- 239000000284 extract Substances 0.000 description 8
- 230000008676 import Effects 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 8
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 7
- 239000004473 Threonine Substances 0.000 description 7
- 230000033228 biological regulation Effects 0.000 description 7
- 235000013339 cereals Nutrition 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 230000000977 initiatory effect Effects 0.000 description 7
- 229960004452 methionine Drugs 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- GHSJKUNUIHUPDF-UHFFFAOYSA-N s-(2-aminoethyl)-l-cysteine Chemical compound NCCSCC(N)C(O)=O GHSJKUNUIHUPDF-UHFFFAOYSA-N 0.000 description 7
- 229960002898 threonine Drugs 0.000 description 7
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 238000013519 translation Methods 0.000 description 6
- 230000014616 translation Effects 0.000 description 6
- 108010055400 Aspartate kinase Proteins 0.000 description 5
- 240000005979 Hordeum vulgare Species 0.000 description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 description 5
- 206010020649 Hyperkeratosis Diseases 0.000 description 5
- 244000062793 Sorghum vulgare Species 0.000 description 5
- 240000008042 Zea mays Species 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 238000012512 characterization method Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 239000006166 lysate Substances 0.000 description 5
- 229930182817 methionine Natural products 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 240000004713 Pisum sativum Species 0.000 description 4
- 108010076504 Protein Sorting Signals Proteins 0.000 description 4
- 108020004511 Recombinant DNA Proteins 0.000 description 4
- 108090001109 Thermolysin Proteins 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 3
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
- 229920002148 Gellan gum Polymers 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 229940009098 aspartate Drugs 0.000 description 3
- 229960003669 carbenicillin Drugs 0.000 description 3
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 235000009973 maize Nutrition 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000004570 mortar (masonry) Substances 0.000 description 3
- 108010058731 nopaline synthase Proteins 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 210000001995 reticulocyte Anatomy 0.000 description 3
- 210000003705 ribosome Anatomy 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000004114 suspension culture Methods 0.000 description 3
- 230000009261 transgenic effect Effects 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- FXWFZIRWWNPPOV-UHFFFAOYSA-N 2-aminobenzaldehyde Chemical compound NC1=CC=CC=C1C=O FXWFZIRWWNPPOV-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 2
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- -1 aspartyl Chemical group 0.000 description 2
- 238000000376 autoradiography Methods 0.000 description 2
- 230000001851 biosynthetic effect Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 108091092328 cellular RNA Proteins 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 108010083942 mannopine synthase Proteins 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 229940076788 pyruvate Drugs 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 229940054269 sodium pyruvate Drugs 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 210000002377 thylakoid Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000005030 transcription termination Effects 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000010455 vermiculite Substances 0.000 description 2
- 229910052902 vermiculite Inorganic materials 0.000 description 2
- 235000019354 vermiculite Nutrition 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 238000003260 vortexing Methods 0.000 description 2
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- GMKMEZVLHJARHF-UHFFFAOYSA-N 2,6-diaminopimelic acid Chemical compound OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- FIZUQXLGABRGSR-UHFFFAOYSA-N 3,4-dihydropyridine-2-carboxylic acid Chemical compound OC(=O)C1=NC=CCC1 FIZUQXLGABRGSR-UHFFFAOYSA-N 0.000 description 1
- UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 1
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 1
- 108010000700 Acetolactate synthase Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 244000106835 Bindesalat Species 0.000 description 1
- 235000000318 Bindesalat Nutrition 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 239000005489 Bromoxynil Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 241001432959 Chernes Species 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 108700003861 Dominant Genes Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010074122 Ferredoxins Proteins 0.000 description 1
- 241000234642 Festuca Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 244000038248 Pennisetum spicatum Species 0.000 description 1
- 235000007195 Pennisetum typhoides Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 102000002278 Ribosomal Proteins Human genes 0.000 description 1
- 108010000605 Ribosomal Proteins Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- 108010016634 Seed Storage Proteins Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 235000008515 Setaria glauca Nutrition 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000015505 Sorghum bicolor subsp. bicolor Nutrition 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108010056371 Succinyl-diaminopimelate desuccinylase Proteins 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000009418 agronomic effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000008687 biosynthesis inhibition Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- JQXXHWHPUNPDRT-YOPQJBRCSA-N chembl1332716 Chemical compound O([C@](C1=O)(C)O\C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CCN(C)CC1 JQXXHWHPUNPDRT-YOPQJBRCSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 238000003370 dye binding method Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000442 meristematic effect Effects 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 230000037425 regulation of transcription Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 239000012882 rooting medium Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
- C12N15/8254—Tryptophan or lysine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
Definitions
- Transgenic plants have also been engineered to resist certain insect pests (Adang, 1985, published European Patent Application No. 142,924 and Vaeck, Nature, 328, 33-37 (1987)), fungal diseases (Taylor, Mol. Gen. Genet., 210, 572-577 (1987)), and viral diseases (Abel, Science, 232, 738-743 (1986) and Nelson, Bio/Technol., 6, 403-405 (1988)).
- Another area of interest is the design of plants, especially crop plants, with added value traits.
- An example of such a trait is improved nutritional quality in food crops.
- Lysine an amino acid essential in the diet of humans and monogastric animals, is among the three most limiting nutrients in most of the cereal crops. Consequently, grain-based diets, such as those based on corn, barley, wheat, rice, maize, millet, sorghum, and the like, must be supplemented with more expensive synthetic lysine or with lysine-containing oilseed protein meals. Increasing the lysine content of these grains or of any of the feed component crops would result in significant added value. To date, attempts to elevate lysine levels in plants have relied on conventional breeding methods and, more recently, mutagenesis and cell culture technology.
- Naturally-occurring high lysine mutants of maize (Mertz, Science, 145, 279 (1964) and Nelson, Science, 150, 1469-1470 (1965)), barley (Munck, Science, 168, 985-987 (1970)), and grain sorghum (Singh et al., Crop Sci., 13, 535-539 (1973)) have been identified.
- the improved lysine content results not from increased free lysine production, but from shifts in the overall protein profile of the grain: the reduced levels of lysine-deficient endosperm proteins (prolamines) are complemented by elevated levels of more lysine-rich proteins (albumins, globulins and glutelins). While nutritionally superior, these mutants are associated with reduced yields and poor grain quality, limiting their agronomic usefulness.
- Lysine is a member of the "aspartate family" of amino acids in higher plants and microorganisms (see Figure 1). As such, the regulation of its biosynthesis is intimately connected to that of the other members of the family: threonine, methionine and isoleucine. Regulation of metabolite flow appears to be chiefly through endproduct feedback inhibition at key enzymatic steps. The first of these steps, the phosphorylation of aspartate catalyzed by aspartate kinase (AK), is common to all four endproducts.
- AK aspartate kinase
- a second site of regulation is at the branch-point reaction: the condensation of pyruvate with aspartyl semialdehyde to form dihydrodipicolinic acid.
- This reaction is the first one unique to the biosynthesis of lysine and is catalyzed by dihydrodipicolinic acid synthase (DHDPS), an enzyme shown to be strongly feedback inhibited by lysine in plants where it has been examined (Wallsgrove et al., Phytochem., 20, 2651-2655 (1981), and Kumpaisal, Plant Physiol., 85, 145-151 (1987)).
- DHDPS dihydrodipicolinic acid synthase
- Lysine analogs in particular S(2-aminoethyl)-cysteine (AEC) have also been used either alone or in conjunction with lysine plus threonine selections in attempts to isolate lysine-overproducing mutants.
- Sano et al. J. Gen. Appl. Microbiol., 16, 373-391 (1970) were able to isolate high lysine bacterial mutants using AEC selection and AEC was proposed to act as a false feedback inhibitor of AK or DHDPS or both. Attempts to isolate similar mutants in plants have had mixed results. Widholm (Can. J.
- the present invention provides a method of substantially increasing the level of free L-lysine in a plant comprising: (a) introducing a foreign gene into the cells of a plant tissue source, and (b) expressing the foreign gene in said cells, wherein said foreign gene comprises a DNA sequence which encodes dihydrodipicolinic acid synthase (DHDPS) which is substantially resistant to feedback inhibition by endogenously-produced free L-lysine.
- said foreign gene comprises a second DNA sequence which is attached to the 5' -terminus of the DHDPS DNA sequence, and which encodes a chloroplast transit peptide (CTP).
- the CTP localizes the DHDPS in the chloroplasts of said cells, where it can act to enhance the biosynthesis of free L-lysine. Therefore, the present method also provides plant cells which have been transformed by the introduction of a foreign gene which expresses a form of DHDPS which is substantially-resistant to feedback inhibition by endogenous lysine. Since techniques are known by which cells from a wide variety of plant tissue sources can be regenerated into whole plants, the present method also provides a transformed plant which produces free L-lysine by a biosynthetic pathway employing DHDPS, wherein the DHDPS is the product of a foreign (exogeneous) gene, and is substantially resistant to feedback-inhibition by endogeneously-produced lysine.
- Preferred plants which are transformed by the present method include the graminaceous species, such as those enumerated hereinabove.
- the edible parts of such transformed plants can have free L-lysine levels which are at least about 50 times higher than the lysine levels in an untransformed plant of the same species.
- the foreign gene employed to transform the plant cells is preferably a chimeric-gene expression cassette comprising a gene coding for DHDPS or an enzymatically-functional fragment thereof which is substantially resistant to feedback inhibition.
- the expression cassette also comprises a second DNA sequence which encodes an amino-terminal chloroplast transit sequence (CTS).
- CTS chloroplast transit sequence
- the DHDPS gene or gene fragment is joined in correct reading frame at its 5'- terminus to the CTS gene.
- the foreign gene is preferably under the transcriptional and translational control of regulatory regions which are functional in the target plant cells. Such regions can be obtained from the DNA sequences which are transferred to plant cells by the Ti or Ri plasmids of A.
- tumefaciens e.g., segments of the "T DNA.”
- a useful transcriptional initiation region can be isolated from a Ti or Ri plasmid gene encoding octopine synthase, nopaline synthase or mannopine synthase.
- the expression cassette preferably further comprises a gene encoding a function that is selectable in plant cells, such as drug or herbicide resistance, so that the transformed cells, and the plants derived therefrom, can be readily identified.
- a further embodiment of the present invention comprises an expression vector such as a plasmid, which incorporates the present expression cassette, wherein said plasmid is capable of replication in a bacterium such as E. coli or Agrobacterium.
- the foreign gene can be introduced into the genome of the plant cells as "naked" DNA by methods such as electroporation, microinjection, microprojectile injection or via liposome encapsulation.
- a plasmid incorporating the foreign gene can be introduced into the genome of the plant cells by A. tumefaciens-mediated transformation.
- the term "foreign" means that the gene or gene fragment is obtained from one or more sources other than the genome of the species of plant within which it is ultimately expressed.
- the source can be natural, e.g., the gene can be obtained from another source of living matter, such as bacteria, yeast, fungi and the like, or a different species of plant.
- a preferred source of a gene encoding functional DHDPS is the E. coli dap A gene.
- the source can also be synthetic, e.g., the gene or gene fragment can be prepared in vitro by chemical synthesis.
- the term "expresses" means that the gene is stably incorporated into the genome of the cells, so that the product encoded by the gene, e.g., an enzyme such as DHDPS, is produced in a functional form within the cells.
- a functional form of DHDPS catalyzes a step in the endogenous biosynthesis of lysine.
- the term "substantially resistant” means that the DHDPS remains functional in the presence of endogenous lysine to the extent that the plant accumulates lysine substantially in excess of that accumulated by a plant of the same species which does not synthesize DHDPS which is so resistant.
- novel plants resulting from the present method contain extractable lysine levels at least about ten times, and preferably, at least about 50 times, e.g., about 50-250 times higher than plants of the same species which contain only native DHDPS.
- free lysine is not present in levels which are toxic to the particular plant species which has been altered.
- plant cells or plants which are referred to as "transformed” have the foreign gene or gene fragment stably, functionally and inheritably integrated into their genome.
- Figure 1 is a schematic depiction of the lysine biosynthetic pathway wherein the following letters indicate the following en zymes : a- -aspartate kinase; b- -aspartyl-semialdehyde dehydrogenase; c- - dihydrodipicolinic acid synthase; d- -dihydrodipicolinic acid reductase; e- -succinyloxoaminopimelate synthase; f- -succinyldiaminopimelate amino transferase; g- - succinyldiaminopimelate desuccinylase; h- -diaminopimelate; and i- -meso-diaminopimelate decarboxylase.
- Figure 2 schematically depicts the manipulation of the dap A gene as described in Example I.
- the present invention relates to a novel method for obtaining plants, such as the grains, that produce elevated levels of free lysine.
- the overproduction results from the introduction and expression of an introduced bacterial gene encoding dihydrodipicolinic acid (DHDP) synthase, the branch-point enzyme in the biosynthesis of lysine in both plants and bacteria.
- DHDP dihydrodipicolinic acid
- Native plant DHDP synthase is highly sensitive to feedback inhibition by L-lysine and constitutes a key site of regulation of the pathway.
- DHDP synthase isolated from Escherichia coli is active in the presence of at least 200-fold higher levels of L-lysine.
- the bacterial DHDP synthase gene In the first place, the bacterial DHDP synthase gene must be modified in vitro to include regulatory signals required for gene expression in plant cells. Because the lysine biosynthetic pathway in plants is reported to be sequestered in the chloroplasts, the bacterial gene is preferably modified to add sequences encoding an amino-terminal chloroplast transit peptide sequence, in order to direct the gene product to these organelles.
- the gene In order to alter the biosynthesis of lysine, the gene must be introduced into the plant cells and these transformed cells identified. The gene must also be stably incorporated into the plant cell genome.
- the transcriptional signals of the gene must be recognized by and be functional in the plant cells. That is, the gene must be transcribed into messenger RNA, and the mRNA must be stable in the plant nucleus and be transported intact to the cytoplasm for translation.
- the gene must have appropriate translational signals to be recognized and properly translated by plant cell ribosomes.
- the polypeptide gene product must escape proteolytic attack in the cytoplasm and be able to assume a three-dimensional conformation that will confer enzymic activity.
- the bacterial DHDP synthase must further be able to function in the biosynthesis of lysine; that is, it must be localized near the native plant enzymes catalyzing the flanking steps in biosynthesis (presumably in the chloroplast) in order to obtain the required substrates (aspartyl semialdchyde and pyruvate) and to pass on the appropriate product (dihydropicolinic acid).
- DHDPS dihydrodipicolinic acid synthase
- a gene encoding dihydrodipicolinic acid synthase (DHDPS) can be obtained from any microorganism that synthesizes lysine by the diaminopimelate pathway.
- a key criterion in the choice of gene is the relative insensitivity of the gene product (DHDPS) to inhibition by lysine.
- One such gene which is a preferred starting material for use in the present method, is the E. coli dap A gene, which encodes a functional 32 kD species of DHDPS which is highly resistant to feedback inhibition by lysine.
- the gene may be isolated from the microorganism by methodologies well known in the art. Such methodologies include screening a genomic library for complementation of a known mutant of DHDPS; immunological screening of polypeptides expressed from gene libraries; screening a genomic library for hybridization to a radiolabelled oligonucleotide probe, and the like.
- the oligonucleotide probe may be synthesized based on sequence derived from genes of other species or from reverse translation of the polypeptide sequence of an isolated DHDPS subunit. Alternatively, the gene may be chemically synthesized wholly or in part.
- the gene is characterized using standard recombinant DNA manipulations and molecular analyses. Such techniques are well known to those in the art and are outlined in Maniatis et al., Molecular cloning: A laboratory manual, Cold Spring Harbor Laboratory, NY (1982).
- the DNA fragment carrying the DHDPS gene is reduced to the smallest functional fragment possible; that is, extraneous DNA flanking the gene is removed by methods such as Bal31 digestion, deletion of a known restriction endonuclease fragment, and the like, to obtain the smallest DNA fragment that will, for example, still complement the DHDPS mutant. This fragment is usually less than three kilobases, more commonly, about one kilobase.
- the nucleotide sequence of this DNA fragment may then be determined by any of several conventional methods.
- the open reading frame (coding sequence), the putative RNA polymerase binding site (promoter), ribosomal binding site, and the transcriptional termination signal sequence are then identified.
- the transcriptional initiation site may be determined by techniques such as Sl-nuclease mapping or primer repair analysis.
- Extracts of bacteria (typically E. coli) incorporating the isolated gene on a plasmid are assayed to confirm the presence of DHDPS activity and the in vitro relative resistance of enzymic activity to added L-lysine.
- the gene is modified to allow integration, expression, and function of the gene product in host plant cells.
- the preferred modifications are: 1) the addition of a DNA sequence coding for an amino-terminal chloroplast transit peptide to the 5' terminus of the DHDPS coding sequence; 2) the replacement of bacterial 5' and 3' regulatory sequences with 5' and 3' regulatory sequences recognized by and functional in plant cells; and 3) insertion of this plant-specific expression cassette into a vector suitable for introducing the DHDPS gene into host plant cells, and stably establishing it therein.
- chloroplast transit peptide DNA sequence
- All lysine biosynthetic enzymes studied in plants to date have been localized in the chloroplasts.
- a DNA fragment encoding a chloroplast transit peptide sequence is attached to the 5' terminus of the DNA sequence coding for DHDPS, in the proper reading frame, whereby a complete transit peptide-DHDPS preprotein will be translated from transcripts of the gene fusion.
- Useful transit peptides (typically 40 to 70 amino acids in length) function post-translationally to direct the preprotein to the chloroplast, where the preprotein is imported in an energy-dependent process.
- the transit peptide is cleaved either during or just after import to yield the mature polypeptide.
- the DNA fragment encoding this transit peptide can be obtained from a variety of plant nuclear genes, so long as the products of said genes are expressed as preproteins comprising an amino-terminal transit peptide and transported into chloroplasts.
- Examples of plant gene products known to include such transit peptide sequences are the small subunit of ribulose bisphosphate carboxylase, ferredoxin, chlorophyll a/b binding protein, chloroplast ribosomal proteins encoded by nuclear genes, certain heat shock proteins, amino acid biosynthetic enzymes such as acetohydroxy acid synthase and 3-enolpyruvylphosphoshikimate synthase, and the like.
- the DNA fragment coding the transit peptide may be chemically synthesized either wholly or in part from the known sequences of transit peptides, such as those listed hereinabove.
- the DNA fragment coding the transit peptide should include a translation initiation codon and encode an amino acid sequence that is recognized by and will function properly in chloroplasts of the host plant. Attention should also be given to the amino acid sequence at the junction between the transit peptide and the mature DHDPS subunit where the preprotein is cleaved to yield mature DHDPS. Certain conserved amino acid sequences have been identified and may serve as a guideline.
- Precise fusion of the transit peptide coding sequence with the DHDPS coding sequence may require manipulation of one or both DNA sequences to introduce, for example, a convenient restriction site. This may be accomplished by methods including site-directed mutagenesis, insertion of a chemically-synthesized oligonucleotide linker, and the like.
- the transit peptide-DHDPS gene expression cassette may be introduced into any of a number of plasmid vectors, so that the gene is placed in the proper orientation under the transcriptional control of a bacteriophage promoter such as SP6, T3, T7 and the like.
- the resultant plasmid is then digested at a unique restriction site 3' to the coding sequence to form a linear DNA molecule.
- This DNA molecule is then subjected to a run-off transcription reaction using an RNA polymerase specific for the promoter being used. Yields of such reactions are typically 10-12 micrograms of essentially pure messenger RNA (mRNA) per microgram of linear DNA template.
- mRNA transcripts are then translated in the presence of one or more radiolabelled amino acids using in vitro translation systems such as wheat germ or rabbit reticulocyte lysate, to yield radiolabelled preprotein.
- the radiolabelled preprotein is then incubated with isolated intact chloroplasts in the presence of light to assay import efficiency.
- the chloroplasts are then treated with a protease or combination of proteases such as thermolysin, trypsin, chymotrypsin, and the like. This treatment degrades any protein not sequestered within the chloroplasts.
- the chloroplasts are lysed using vortexing, freeze/thaw treatment, reduced osmoticum or a combination of these.
- the lysate may be: (a) assayed directly, (b) it may be first subjected to immunoprecipitati ⁇ n using DHDPS subunit antibacterial antiserum generated by standard protocols, (c) it may be centrifuged to separate stromal proteins (supernatant) from .proteins localized in the thylakoid membranes (pellet), (d) or a combination of these processes may be used. SDS-polyacrylamide gel analysis is used to confirm the presence or absence of a radiolabelled protein band corresponding to the molecular weight of the mature bacterial DHDPS subunit. The presence of the band indicates that the preprotein has been imported and processed to the correct size.
- RNA polymerase binding site promoter
- regions required for regulation of transcription where the regulation is mediated by chemical or physical induction or repression.
- Examples of such regulation include light-induced expression of ribulose bisphosphate carboxylase small subunit, heat-induced expression of heat shock proteins, genes regulated by plant hormones or other metabolites, developmentally regulated expression, wound- or stress-induced expression, and the like.
- the 5' sequences may also include transcriptional enhancer sequences.
- the 5' regions may be native to the host plant, or may be derived from other plants where the sequences are functional in the host plant. Suitable sequences may also be obtained from genes of the Ti plasmid of Agrobacterium tumefaciens, including octopine synthase, nopaline synthase, mannopine synthase, and the like, or may be obtained from certain viral genes.
- the transcriptional initiation region may be chemically synthesized either wholly or in part.
- the 3' region will include transcriptional termination sequences and may include polyadenylation signal sequences. This region may be derived from the same gene as the 5' sequences or from a different gene. These sequences may also be chemically synthesized.
- the resultant expression cassette will comprise a 5' transcriptional initiation region, a chloroplast transit peptide coding sequence, the bacterial DHDPS subunit coding sequence, a translational stop codon, and a 3' transcriptional termination region.
- the cassette will usually include less than five kilobases, and preferably will include between two and three kilobases.
- a vector for introducing the bacterial DHDPS expression cassette into plant cells will depend on the choice of the transformation method which will, in turn, depend on the host plant and the choice of plant tissue source.
- a wide variety of protocols are available for the introduction of foreign DNA into the cells of both monocots and dicots, including the use of microprojectiles, microinjection, electroporation, incubation with Ca ++ -precipitated DNA, incubation with liposomes containing the foreign DNA (preferably in the presence of PVA and Ca +2 ), viral systems, and Agrobacterium-mediated transformation. See M.
- the expression cassette will be included in a vector, and flanked by fragments of the Agrobacterium Ti or Ri plasmid, representing the right and, optionally the left, borders of the Ti or Ri plasmid transferred DNA (T-DNA). This facilitates integration of the foreign gene into the genome of the host plant cell.
- This vector will also contain sequences that facilitate replication of the plasmid in Agrobacterium cells, as well as in E. coli cells.
- All DNA manipulations are typically carried out in E. coli cells, and the final plasmid bearing the DHDPS expression cassette is moved into Agrobacterium cells by direct DNA transformation, conjugation, and the like.
- These Agrobacterium cells will contain a second plasmid, also derived from Ti or Ri plasmids. This second plasmid will carry all the vir ge nes required for transfer of the foreign DNA into plant cells.
- identification of transformed plant cells is facilitated by including a gene encoding a function that is selectable in plant cells.
- Preferred genes are those encoding resistance to a chemical normally inhibitory to plant cells, such as resistance to hygromycin, kanamycin, methotrexate, and certain herbicides.
- the selectable marker may be carried on a separate plasmid that is co-transformed with the DHDPS-bearing plasmid, or may be carried on the same plasmid as the DHDPS cassette. In the case of Agrobacterium-mediated transformation, the selectable marker can be contained within the region of the plasmid flanked by the T-DNA border regions.
- a screenable marker such as the 3-glucuronidase gene may be used in place of a selectable marker.
- Cells transformed with this gene may be identified by the production of a blue product on treatment with 5-bromo-4-chloro-3-indoyl- ⁇ -D-glucuronide (X-Gluc).
- tissue source for transformation will depend on the nature of the host plant and the transformation protocol.
- Useful tissue sources include callus, suspension culture cells, protoplasts, leaf segments, stem segments, tassels, pollen, embryos, hypocotyls, tuber segments, meristematic regions, and the like.
- the tissue source will retain the ability to regenerate, whole, fertile plants following transformation.
- the transformation is carried out under conditions directed to the plant tissue of choice.
- the plant cells or tissue are exposed to the DNA carrying the DHDPS expression cassette for an effective period of time. This may range from a less-than-one-second pulse of electricity for electroporation, to a two-to-three day co-cultivation in the presence of plasmidbearing Agrobacterium cells. Buffers and media used will also vary with the plant tissue source and transformation protocol. Many transformation protocols employ a feeder layer of suspended culture cells (tobacco or Black Mexican Sweet, for example) on the surface of solid media plates, separated by a sterile filter paper disk from the plant cells or tissues being transformed.
- suspended culture cells tobacco or Black Mexican Sweet, for example
- the plant cells or tissue may be cultivated for varying lengths of time prior to selection, or may be immediately exposed to a selective agent such as those described hereinabove. Protocols involving exposure to Agrobacterium will also include an agent inhibitory to the growth of the Agrobacterium cells. Commonly used compounds are cefotaxime and carbenicillin.
- the media used in the selection may be formulated to maintain transformed callus or suspension culture cells in an undifferentiated state, or to allow production of shoots from callus, leaf or stem segments, tuber disks, and the like.
- Cells or callus observed to be growing in the presence of normally inhibitory concentrations of the selective agent are presumed to be transformed and may be subcultured several additional times on the same medium to remove non-resistant sections.
- the cells or calli can then be assayed for the presence of the bacterial DHDPS gene cassette, or may be subjected to known plant regeneration protocols.
- protocols involving the direct production of shoots those shoots appearing on the selective media are presumed to be transformed and may be excised and rooted, either on selective medium suitable for the production of roots, or by simply dipping the excised shoot in a root-inducing compound and directly planting it in vermiculite.
- the bacterial gene In order to produce transgenic plants exhibiting elevated free lysine levels, the bacterial gene must be taken up into the plant cell and stably integrated within the plant genome. Plant cells and tissues selected for their resistance to an inhibitory agent are presumed to have acquired the gene encoding this resistance during the transformation treatment. Since this marker gene is commonly linked to the bacterial DHDP synthase gene, it can be assumed that the bacterial DHDP synthase gene has similarly been acquired. Southern blot hybridization analysis using a probe specific to the bacterial DHDP synthase gene can then be used to confirm that the foreign gene has been taken up and integrated into the genome of the plant cell. This technique may also give some indication of the number of copies of the gene that have been incorporated. Successful transcription of the foreign gene into mRNA can likewise be assayed using Northern blot hybridization analysis of total cellular RNA and/or cellular RNA that has been enriched in a polyadenylated region.
- Plant cells or tissues shown both to carry and transcribe the bacterial DHDP synthase gene may be further characterized by extraction of the cells or tissues and demonstration of lysine-tolerant DHDP synthase activity. This in vitro lysine tolerance is preferably comparable to that observed in extracts of the microorganism that served as the source of the gene and should be readily distinguishable from the more highly lysine-sensitive native DHDP synthase activity which can be extracted from control plant cells or tissues.
- the activity may be detected in all plant tissues, in selected tissues, or only under selected inducing conditions. Regardless of the location of the bacterial DHDP synthase activity in the plant, it must be localized within the plant cell so that it can participate in the biosynthesis of lysine, catalyzing the conversion of substrates into product. The ability of the bacterial DHDP synthase to so participate may be assessed by determining the relative tolerance of plant cells or tissues to the lysine analog S-(2-aminoethyl)-cysteine (AEC). Like lysine, AEC is a potent inhibitor of plant DHDP synthase.
- Plant cells or tissues exposed to inhibitory concentrations of AEC are effectively starved for lysine.
- DHDP synthase from E. coli is considerably less sensitive to this inhibition.
- the ability of plant cells or tissues expressing active bacterial DHDP synthase to tolerate normally inhibitory concentrations of AEC strongly suggests that the bacterial enzyme is functioning properly in the biosynthesis of lysine.
- free lysine may accumulate to levels higher than seen in control plant cells or tissues. Free amino acid levels may be readily measured by techniques such as reverse phase HPLC analysis of trichloroacetic acid (TCA) extracts of transgenic plant cells or tissues.
- TCA trichloroacetic acid
- Plants that accumulate significantly elevated levels of free lysine in accord with these mechanisms are grown to maturity. These plants are allowed to flower and are self-pollinated or crossed to an appropriate parental line to obtain seed. This seed may then be analyzed for inheritance of the desired trait. An initial screen of the seed may be germination and seedling growth in the presence of concentrations of AEC that will inhibit the growth of seedlings germinated from control seed. Seedlings demonstrating AEC tolerance may be grown up and fully characterized as described hereinabove for the original regenerate plants.
- Plants that may be improved by such a transformation include but are not limited to processed plants (soybeans, canola, potatoes, tomatoes, lupins, sunflower and cottonseed), forage plants (alfalfa, clover and fescue), and the grains (corn, wheat, barley, oats, rice, sorghum, millet and rye).
- the plants or plant parts may be used directly as feed or food or the lysine may be extracted for use as a feed or food additive.
- Agrobacterium tumefaciens strain LBA4404 (pAL4404) (Hoekema et al., Nature, 303, 179-180 (1983)) was used for all plant cell transformations.
- the gene was isolated from an Escherichia coli genomic library (Clarke and Carbon Collection of Hybrid Plasmids, Yale University School of Medicine, New
- Fragments of a plasmid (pLC1730) reported to carry the dap A gene were subcloned into cloning vector pBR322. Fragments carrying the dap A gene were identified by complementation of a dap A mutant of E. coli and confirmed by demonstration of a plasmidencoded protein of molecular mass 32 kilodaltons (corresponding to the molecular mass of the dihydrodipicolinic acid synthase subunit) and by dihydrodipicolinic acid synthase enzymatic activity. The nucleotide sequence for one such plasmid construct was determined, and putative promoter sequences and a coding sequence for the dap A gene were identified. Extraneous flanking DNA was removed by further subcloning.
- pDAP1763 carries the entire dap A coding sequence plus 5' and 3' untranslated regions on a 1564 bp Ndel-BstEII fragment.
- pDAP1205 carries a 1375 bp NdeI-SphI fragment that is missing the last thirteen bases of the coding sequence and all untranslated 3' sequences.
- Both plasmids are pBR322 derivatives.
- a DNA sequence encoding a pea chloroplast transit peptide was constructed by first synthesizing subfragments of the sequence and then combining them. Based on the published sequence for the chloroplast transit peptide of a ribulose bisphosphate carboxylase small subunit gene of pea (Cashmore, in: Genetic Engineering of Plants, A. Hollaender, ed., Plenum Press (1983)), eight oligonucleotides (four per strand) were chemically synthesized. The six internal 5' termini bases were phosphorylated using T4 polynucleotide kinase, then 100 pmoles of all eight oligonucleotides were mixed together in a total volume of 70 ⁇ l.
- the 5' terminus of the dap A coding sequence was modified to create an SphI site. This was accomplished by replacing the 108 bp NsiI-NruI fragment in pDAP1763 with a 29 bp synthetic linker which regenerated both the NsiI and the NruI sites. This procedure deleted the bacterial promoter for dap A and changed the sequence surrounding the start codon from CCATGT to GCATGC, thus creating the required SphI restriction site. This change is predicted to result in a phenylalanine-to-leucine substitution at position two in the amino acid sequence. This plasmid was designated pDAP1900.
- the 865 bp SphI fragment of pDAP1900 which includes the dap A coding sequence (less the last thirteen base pairs) was ligated into SphI-digested pSTP31 such that the 5'-terminus of the dap A coding sequence was fused to the 3'-terminus of the synthetic transit peptide sequence and the natural cleavage site of the pea small subunit preprotein was restored.
- the resultant plasmid was designated pDAP4001.
- the polylinker in this plasmid provided a Sad site just 3' to the end of the coding sequence.
- the 3'-terminus of the dap A coding sequence was similarly modified to do four things: (1) destroy the SphI site (rendering the site created at the 5'-terminus unique), (2) restore the last four amino acids of the sequence which had been lost in the original construction of pDAP1205, (3) add two stop codons, and (4) create a BamHI site adjacent to the end of the coding sequence.
- pDAP1252 was digested with BamHI and HindIII and ligated to a 260 bp BamHI-HindIII fragment from pRL101 containing the transcription termination and polyadenylation signal sequences from the nopaline synthase (nos) gene of pTiC58 (nucleotides 673 to 422, Bevan et al. NAR, 11, 369-385 (1983)). This construct was designated pDAP1264.
- pDAP1264 was digested with BstEII (in the middle of the dap A coding sequence) and EcoRI (just 3' to the end of the nos poly A sequence) and ligated into BstEII-EcoRI-digested pDAP4104.
- This plasmid, pDAP4201 carried the synthetic chloroplast transit peptide (STP) sequence fused to the coding sequence of dap A and the nos 3' region, all under the transcriptional control of the SP6 promoter in pGEM3. This construction was used for in vitro analyses of transit peptide function, as described in Section 4, hereinbelow.
- the STP :: dap A :: nos 3' cassette described hereinabove was placed under the control of the 35S promoter of CaMV as follows.
- Plasmid p35-227 was derived from pPol26 by inserting the 450 bp BamHI-BgIII fragment carrying the 35S promoter sequence from pCaMVPRO (a gift from V. Walbot; see Fromm et al., PNAS, 82, 5824-5828 (1985)) into the BamHI site of the pPo126 polylinker. This construction placed a HindIII site just 3' to the promoter.
- the mRNA was ethanol-precipitated, resuspended in 25 ⁇ l sterile distilled deionized water and quantitated spectrophotometrically. Eight micrograms of this mRNA were used in an in vitro translation reaction (rabbit reticulocyte lysate) which included 2.5 ⁇ Ci/ ⁇ l- 35 S-methionine (New England Nuclear, Boston, MA) in 145 ⁇ l total volume. The reaction mixture was incubated at 30°C for 90 minutes and stopped by placing it on ice.
- a second sample taken at 15 minutes was pipetted into a tube on ice containing 7 ⁇ l 10 mM CaCl 2 as control. All tubes were incubated on ice for 20 minutes, then diluted with 150 ⁇ l import buffer containing 50 mM EDTA to inhibit thermolysin. After centrifuging for 10 seconds, the chloroplasts were resuspended in 50 ⁇ l lysis buffer (10 mM HEPES pH 7.5, 10 mM EDTA, 1 mM PMSF, 30- ⁇ g/ml aprotinin) and were lysed by two cycles of freeze/thawing and v ⁇ rtexing. The lysates were centrifuged at 14,000 x g for 20 minutes to separate the stromal (supernatant) and thylakoid (pellet) fractions.
- the following section describes the construction of the vector used for the introduction of the modified dap A into plant cells.
- the vector comprises the left and right. T-DNA borders of pTiAch5 to facilitate integration of the gene into the plant genome, a selectable marker for E. coli (ampicillin resistance), a selectable marker for Agrobacterium tumefaciens and tobacco, (kanamycin resistance), and origin of replication sequences to allow plasmid replication in both E. coli and Agrobacterium tumefaciens.
- the left border of the pTiAch5 T L DNA was obtained by digesting pOTY8 (Hoekema, supra) with BamHI and ClaI and then isolating a 1206 bp fragment (nucleotides 1 to 1206 according to Barker et al., Plant Mol. Biol., 2 , 335-350 (1983); see also DeVos et al., Plasmid, 6, 249-253 (1981)). The fragment was ligated into BglII-ClaI-digested pPo126 to give plasmid pOTBL1.
- the right border was similarly obtained from pOTY8 as a 5766 bp HpaI-XhoI fragment inserted into the polylinker region of pPo126 digested with HpaI and XhoI to make pTB11828.
- the broad host range origin of replication of pSa was isolated by digesting pUCD2 (Close et al., Plasmid, 12, 111-118 (1984)) with HincII and BamHI.
- the 2900 bp ori fragment was ligated with HpaI-BglII-digested pPol26 to give pPo1Sa.
- the left and right T-DNA borders and the pSa ori were inserted into pBR322 as follows.
- pOTBL1 was digested with ClaI and HindIII (nucleotide 602, Barker, supra) to generate a 604 bp fragment which was then made bluntended with the Klenow fragment of DNA polymerase.
- the DNA fragment was inserted into the PvuII site of pBR322 to give pBR322L.
- the right border was carried on a 912 bp ClaI-BamHI fragment from pTB11828 (nucleotides 13774 to 14686, Barker, supra) and was ligated into ClaI-BamHI-digested pBR322L to make
- the hybrid ClaI site of pBR322LR was sensitive to methylation to E. coli strain MC1000 and therefore refractory to digestion by ClaI.
- a selectable marker capable of conferring kanamycin resistance in both Agrobacterium and in plants was constructed by using the promoter from transcript 24 of the pTiAch5 TR DNA. This promoter region was isolated as a 1503 bp EcoRI-ClaI fragment from pRK290-Eco ⁇ Cla (Gelvin et al., Mol. Gen. Genet., 199, 240-248 (1985)) representing nucleotides 21,631 to 20,128 (Barker, supra). The fragment was ligated into pPol26 digested with EcoRI and ClaI to make pPolPTR.
- a BamHI site in the polylinker just 3' to the transcript 24 promoter was used to insert a 1500 bp BgIII-BamHI fragment from Tn5 (Rothstein et al., Cell, 19, 795-805 (1980)). This fragment contains the neomycin phosphotransferase II
- NPTII NPTII
- Polyadenylati ⁇ n signal sequences from the octopine synthetase (ocs) gene of pTiAch5 were isolated as a 707 bp PvuII fragment from pTB11828 (nucleotides 12,5541 to 11,834, Barker, supra). This fragment was ligated into SmaI-digested pPo1NPTII, replacing 500 bp of extraneous Tn5 sequences 3' to the NPTII coding sequence. Correct orientation of the poly A fragment was confirmed by the fragment pattern generated by digestion with XmaIII. The plasmid was designated pPo1NPTII-A.
- the pTR :: NPTII :: ocs 3' gene cassette was moved as a 3100 bp XhoI fragment from pPo1NPTII-A into SalI-digested pBR322LRSa to make pBVl.
- This 11.5 kilobase plasmid contained - in a clockwise orientation from the unique EcoRI site - the following components: the broad host range pSa ori, the right border, cloning sites HpaI and BamHI, the pTR/NPTII/ocs chimeric gene (transcribed clockwise), 1415 bp of pBR322 (SalI to PvuII), the left border, and the PvuII-EcoRI fragment of pBR322 which includes the origin of replication and the ampicillin resistance gene.
- pDAP4511 a 1830 bp BamHI (partial)-HpaI fragment of pDAP4307 was ligated into HpaI-BamHI-digested pBVl to give pDAP4511.
- the dap A gene is also just ahead of the NPTII selectable marker, but in the opposite orientation, such that it is transcribed divergently with respect to the NPTII.
- pDPZ4474 ATCC No. 67721
- pDAP4511 were each transformed into Agrobacterium tumefaciens LBA4404 (pAL4404) using the method described in VanVliet et al., Plasmid, 1, 446-455 (1978). Transformants were selected on plates containing kanamycin (50 ⁇ g/ml) and streaked out for single colony purity.
- Agrobacterium tumefaciens LBA4404 (pAL4404) carrying pDPZ4474, pDAP4511, or pBV1 were used in co-cultivation transformations of tobacco leaf disks.
- One set of disks was treated with sterile water as a negative control.
- Leaf disks of Nicotiana tabacum SRI plants were transformed essentially as described in Horsch et al., Science, 227, 1229-1231 (1985) with the following exceptions: Agrobacterium cultures were grown in 523 medium (Kado et al., Physiol.
- the leaf disks were placed on shooting medium (same as nurse medium, but containing 500 ⁇ g/ml carbenicillin and kanamycin at 0, 100 or 200 ⁇ g/ml and lacking feeder cultures or filter paper). Plates were sealed with parafilm and incubated at 26°C with a 12-hour photoperiod. Shoots were excised when they reached 1 cm and were transferred to rooting medium (no hormones) containing carbenicillin and kanamycin at the same concentration on which the shoot originated. When roots appeared, the plantlets were placed in vermiculite and then transplanted to soil.
- shooting medium standard as nurse medium, but containing 500 ⁇ g/ml carbenicillin and kanamycin at 0, 100 or 200 ⁇ g/ml and lacking feeder cultures or filter paper. Plates were sealed with parafilm and incubated at 26°C with a 12-hour photoperiod. Plants were excised when they reached 1 cm and were transferred to rooting medium (no hormones) containing carbenicillin and kanamycin at the same concentration on which
- Plant tissue was initially screened for expression of the introduced dap A gene by evaluating resistance to the lysine analog S(2-aminoethyl)cysteine (AEC).
- AEC is a potent inhibitor of dihydrodipicolinic acid synthase of plants, but the bacterial DHDPS is much less sensitive to it.
- Leaf disks were prepared from surface-sterilized leaves as described in the transformation protocol. The disks were placed, (four disks per plate, two plates per treatment) on shooting medium supplemented with 1 mM L-arginine and AEC at 0, 0.1, 0.2 or 0.4 mM. Plates containing shooting medium supplemented with 75 ⁇ g/ml kanamycin were included for each plant tested to check the selectable marker. After one week at 26°C in the light * the individual leaf disks were weighed and the average fresh weight and standard deviation were determined for each treatment.
- Leaf disks from all plants remained green and expanded in the absence of AEC. Fresh weight per disk increased from about 9 mg to about 60 mg in 1 week.
- Leaf disks plated on medium containing at least 0.2 mM AEC were brown and shriveled.
- leaf disks from putative dap A+ plants were readily identified by their ability to remain green and growing in the presence of AEC.
- Many AEC-tolerant plants were identified using this screening procedure. The characterization of one such plant is described below in detail.
- Young leaves of 327 and seed-grown NT-SRI plants were extracted as follows. One to two grams of deribbed leaves were ground at 4°C in 2 ml extraction buffer (0.1 M potassium phosphate (pH 7.5 at 4°C), 2 mM EDTA, 1 mM ⁇ - mercaptoethanol, 10 mM sodium pyruvate) in the presence of 0.14 gm polyvinylpyrrolidone per gram of tissue. The extract was filtered through Miracloth (Calbiochem) and then centrifuged for 10 minutes at 8000 x g (4°C). The supernatant was slowly brought to 40% saturation by adding finely ground solid ammonium sulfate at 4°C with gentle stirring. The precipitate was removed by centrifugation.
- 2 ml extraction buffer 0.1 M potassium phosphate (pH 7.5 at 4°C), 2 mM EDTA, 1 mM ⁇ - mercaptoethanol, 10 mM sodium pyruvate
- the supernatant was brought to 66% ammonium sulfate saturation and the 40-66% precipitate was collected by centrifugation as before.
- the pellet was resuspended in column buffer (50 mM Tris-HCl (pH 7.5 at 4°C), 1 mM EDTA, 10 mM sodium pyruvate, 10% glycerol) and passed through a Sephadex G-25 column (Sigma) to desalt.
- Protein concentrations were determined by the dye-binding method of Bradford (REF) using bovine serum albumin fraction V powder in distilled water as the standard.
- Dihydrodipicolinic acid synthase activity was monitored using the o-aminobenzaldehyde (ABA) assay (Yugari et al., 3. Biol. Chern., 240, 4710-4716 (1965)).
- L-lysine hydrochloride stock solutions were made in distilled water, filter-sterilized, and added at the indicated concentrations at the beginning of the enzyme reaction.
- 200 ⁇ l aliquots were removed and the reaction quenched in 800 ⁇ l of stop buffer (0.21 M citric acid, 0.53 M sodium phosphate (pH 5 at 25°C), with 0.24 mg o-ABA added just prior to use from a freshly-made 10 mg/ml absolute ethanol stock).
- the pink color was allowed to develop for one hour at 25°C and then the optical density was measured at 520 nm.
- DHDP synthase activity in the leaves of 327 was approximately 30-fold higher than that in leaves of seed-grown NT-SRl. More significantly, the enzyme activity in 327 leaves was completely resistant to added L-lysine at 100 ⁇ M and only 14% inhibited in the presence of 500 ⁇ M L-lysine. In contrast, 100 ⁇ M L-lysine inhibited the DHDP synthase activity in NT-SR1 leaves by 87% and no activity could be detected at 500 ⁇ M L-lysine. 3. Southern/Northern hybridization analysis
- Genomic DNA was isolated from leaves of transformed plants and 101 according to the method of Shure et al., Cell, 35, 225-233 (1983). Ten micrograms of DNA from each plant was digested separately with BamHI and with BstEII and electrophoresed through 0.7% agarose. Digestion with BamHI produces a diagnostic 1540 bp internal fragment, whereas BstEII cuts once in the dap A coding sequence. The gel was blotted to a nylon membrane and hybridized (Southern, J ⁇ Mol. Biol., 98, 503-517 (1975)), using the 1540 bp BamHI fragment of pDAP4307 labelled with 32 P as a probe.
- Trichloroacetic acid (TCA) extracts of leaves from 327 and 101 were prepared to assay free amino acid levels. Young leaves (1-2 gm) were diced into an ice cold mortar, covered with liquid nitrogen, and ground to a powder. The ground leaves were lyophilized overnight and dry weights determined. Each lyophilized sample was returned to a cold mortar and reground in the presence of 2 ml 10% TCA. The mortar was rinsed with an additional 2 ml of TCA. The TCA extracts were combined and incubated on ice for 30 minutes with occasional vortexing. The extraction mixture was centrifuged for 20 minutes (4°C) and the supernatant was removed and placed on ice.
- TCA Trichloroacetic acid
- the pellet was re-extracted with 2 ml 10% TCA as before and the supernatants were pooled. Two milliliters of the pooled extract were extracted three times with 5 ml ether. The ether extract was stored at -70°C until analyzed.
- Free amino acid levels were determined by reverse phase HPLC using the o-phthaldialdehyde derivatization method of Jones et al., 3.
- Root lengths measured at two weeks post-plating. Average root lengths were determined for each AEC treatment and results are expressed as percent of average root length on medium lacking AEC.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US204388 | 1988-06-09 | ||
US07/204,388 US5258300A (en) | 1988-06-09 | 1988-06-09 | Method of inducing lysine overproduction in plants |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0429458A1 EP0429458A1 (en) | 1991-06-05 |
EP0429458A4 true EP0429458A4 (en) | 1991-11-06 |
EP0429458B1 EP0429458B1 (en) | 1994-01-26 |
Family
ID=22757690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP89905254A Expired - Lifetime EP0429458B1 (en) | 1988-06-09 | 1989-03-29 | Method of inducing lysine overproduction in plants |
Country Status (11)
Country | Link |
---|---|
US (1) | US5258300A (en) |
EP (1) | EP0429458B1 (en) |
JP (1) | JP3083531B2 (en) |
CN (1) | CN1045995C (en) |
AR (1) | AR243236A1 (en) |
AU (1) | AU3540289A (en) |
CA (1) | CA1338349C (en) |
DE (1) | DE68912783T2 (en) |
HU (1) | HU214630B (en) |
RO (1) | RO111473B1 (en) |
WO (1) | WO1989011789A1 (en) |
Families Citing this family (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7705215B1 (en) | 1990-04-17 | 2010-04-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US5550318A (en) * | 1990-04-17 | 1996-08-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US6803499B1 (en) | 1989-08-09 | 2004-10-12 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
HU220773B1 (en) | 1990-01-22 | 2002-05-28 | Dekalb Genetics Corporation | Process for producing productive transgenic maize plants |
US6025545A (en) * | 1990-01-22 | 2000-02-15 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US5484956A (en) * | 1990-01-22 | 1996-01-16 | Dekalb Genetics Corporation | Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin |
US6329574B1 (en) | 1990-01-22 | 2001-12-11 | Dekalb Genetics Corporation | High lysine fertile transgenic corn plants |
US6777589B1 (en) * | 1990-01-22 | 2004-08-17 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US6946587B1 (en) | 1990-01-22 | 2005-09-20 | Dekalb Genetics Corporation | Method for preparing fertile transgenic corn plants |
US6395966B1 (en) | 1990-08-09 | 2002-05-28 | Dekalb Genetics Corp. | Fertile transgenic maize plants containing a gene encoding the pat protein |
US5306862A (en) * | 1990-10-12 | 1994-04-26 | Amoco Corporation | Method and composition for increasing sterol accumulation in higher plants |
US5367110A (en) * | 1990-11-13 | 1994-11-22 | Yeda Research And Development Co. Ltd. | Transgenic plants overproducing threonine and lysine |
MX9200621A (en) * | 1991-02-14 | 1993-02-01 | Du Pont | GENE OF A PROTEIN WITH HIGH SULFUR CONTENT OF A SEED AND METHOD TO INCREASE THE SULFUR CONTENT IN AMINO ACIDS OF PLANTS. |
USRE36449E (en) * | 1991-03-05 | 1999-12-14 | Rhone-Poulenc Agro | Chimeric gene for the transformation of plants |
FR2673643B1 (en) | 1991-03-05 | 1993-05-21 | Rhone Poulenc Agrochimie | TRANSIT PEPTIDE FOR THE INSERTION OF A FOREIGN GENE INTO A PLANT GENE AND PLANTS TRANSFORMED USING THIS PEPTIDE. |
US5773691A (en) * | 1992-03-19 | 1998-06-30 | E. I. Du Pont De Nemours And Company | Chimeric genes and methods for increasing the lysine and threonine content of the seeds of plants |
DE69334163T2 (en) * | 1992-03-19 | 2008-04-30 | E.I. Dupont De Nemours And Co., Wilmington | Nucleic acid fragments and methods for increasing the lysine and threonine content of plant seeds |
US5545545A (en) * | 1993-04-27 | 1996-08-13 | Regents Of The University Of Minnesota | Lysine-insensitive maize dihydrodipicolinic acid synthase |
US6326527B1 (en) | 1993-08-25 | 2001-12-04 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
US5780709A (en) * | 1993-08-25 | 1998-07-14 | Dekalb Genetics Corporation | Transgenic maize with increased mannitol content |
US6118047A (en) * | 1993-08-25 | 2000-09-12 | Dekalb Genetic Corporation | Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction |
US6281411B1 (en) | 1993-08-25 | 2001-08-28 | Dekalb Genetics Corporation | Transgenic monocots plants with increased glycine-betaine content |
KR960706564A (en) * | 1993-11-30 | 1996-12-09 | 미리암 디. 메코너헤이 | Chimeric Genes and Methods for Increasing the Lysine Content of the Seeds of Corn, Soybean and Rapeseed Plants |
JPH07155184A (en) * | 1993-12-08 | 1995-06-20 | Ajinomoto Co Inc | Production of l-lysine by fermentation method |
US5859335A (en) * | 1994-12-08 | 1999-01-12 | Novartis Finance Corporation | Enhanced biotin biosynthesis in plant tissue |
EP0819176A1 (en) * | 1994-12-30 | 1998-01-21 | Seminis Vegetable Seeds, Inc. | Transgenic plants exhibiting heterologous virus resistance |
US5869719A (en) * | 1995-03-08 | 1999-02-09 | Novartis Finance Corporation | Transgenic plants having increased biotin content |
SK284047B6 (en) * | 1995-06-13 | 2004-08-03 | Ajinomoto Co., Inc. | Process for producing L-lysine by fermentation |
EP0871356A1 (en) * | 1995-08-29 | 1998-10-21 | University Of Hawaii | Production of transgenic plants comprising the winged bean lysine- rich protein |
US5703049A (en) * | 1996-02-29 | 1997-12-30 | Pioneer Hi-Bred Int'l, Inc. | High methionine derivatives of α-hordothionin for pathogen-control |
US6080913A (en) * | 1996-09-25 | 2000-06-27 | Pioneer Hi-Bred International, Inc. | Binary methods of increasing accumulation of essential amino acids in seeds |
US6800726B1 (en) | 1996-11-01 | 2004-10-05 | Pioneer Hi-Bred International, Inc. | Proteins with increased levels of essential amino acids |
BR9811256A (en) * | 1997-03-27 | 2000-07-18 | Du Pont | Nucleic acid fragment, chimeric gene, plant cell, plant seed, method to reduce lysine ketoglutarate reductase activity in a plant and plant seed |
US6169232B1 (en) | 1997-07-15 | 2001-01-02 | Dow Agrosciences Llc | Nucleotide sequences of genes encoding sink protein and uses thereof for improving the nutritional quality of feeds |
US6322792B1 (en) | 1998-11-19 | 2001-11-27 | Elliott D. Kieff | Rhadino virus LANA acts in trans on a unit of rhadino virus DNA to mediate efficient episome persistance |
US20030084475A1 (en) * | 1999-09-30 | 2003-05-01 | Cahoon Edgar B. | Nucleic acid fragments and proteins affecting storage organelle formation and methods of use |
WO2001046393A2 (en) * | 1999-12-21 | 2001-06-28 | E.I. Du Pont De Nemours And Company | Aspartate kinase |
GB2357766A (en) * | 1999-12-24 | 2001-07-04 | Univ Wales Aberystwyth | Production of heterologous proteins |
EP1970442B1 (en) | 2002-05-03 | 2017-01-18 | Monsanto Technology LLC | Transgenic high tryptophan plants |
US7078234B2 (en) | 2002-12-18 | 2006-07-18 | Monsanto Technology Llc | Maize embryo-specific promoter compositions and methods for use thereof |
BRPI0408896A (en) | 2003-03-28 | 2006-04-25 | Monsanto Technology Llc | plant promoters for use in early seed development |
US8008545B2 (en) | 2003-04-15 | 2011-08-30 | Basf Plant Science Gmbh | Process for the production of fine chemicals |
BRPI0413118A (en) | 2003-08-01 | 2006-10-03 | Basf Plant Science Gmbh | nucleic acid construction, vector, host cell, process for the production of a polypeptide, polypeptide, antibody, plant tissue, propagating material, collected material or a plant, method for the evaluation of agonists and antagonists of an activity of a coded polypeptide by nucleic acid molecule, process for identifying a compound that confers increased fine chemical production in a plant or microorganism, method for identifying a genetic product that confers an increase in fine chemical production in a cell, method for the production of an agricultural composition, composition, and, use of the nucleic acid molecule, polypeptide, or nucleic acid construct, or identified genetic product. |
US7157281B2 (en) * | 2003-12-11 | 2007-01-02 | Monsanto Technology Llc | High lysine maize compositions and event LY038 maize plants |
US7855323B2 (en) * | 2004-02-10 | 2010-12-21 | Monsanto Technology Llc | Recombinant DNA for gene suppression |
US7683237B2 (en) * | 2004-02-10 | 2010-03-23 | Monsanto Technology Llc | Maize seed with synergistically enhanced lysine content |
BRPI0510746A (en) | 2004-06-10 | 2007-11-20 | Univ Michigan State | synthesis of caprolactam from lysine |
EP1765857A2 (en) | 2004-07-02 | 2007-03-28 | Metanomics GmbH | Process for the production of fine chemicals |
MX2007007040A (en) | 2004-12-17 | 2008-10-24 | Metanomics Gmbh | Process for the control of production of fine chemicals. |
US20060150286A1 (en) * | 2004-12-23 | 2006-07-06 | Shihshieh Huang | Gene suppression in transgenic plants using multiple constructs |
US20060242736A1 (en) * | 2004-12-23 | 2006-10-26 | Shihshieh Huang | Dissimilar promoters for gene suppression |
AU2006217847B2 (en) | 2005-02-26 | 2011-04-07 | Basf Plant Science Gmbh | Expression cassettes for seed-preferential expression in plants |
EP2573188A2 (en) | 2005-03-02 | 2013-03-27 | Metanomics GmbH | Process for the production of fine chemicals |
CA2598792A1 (en) | 2005-03-02 | 2006-09-08 | Metanomics Gmbh | Process for the production of fine chemicals |
DE102005012639A1 (en) * | 2005-03-18 | 2006-09-21 | Süd-Chemie AG | Process for the separation of biomolecules from liquid media |
AU2006257101B2 (en) * | 2005-04-19 | 2011-04-28 | Basf Plant Science Gmbh | Starchy-endosperm and/or germinating embryo-specific expression in mono-cotyledonous plants |
AU2006237346B2 (en) | 2005-04-20 | 2011-04-07 | Basf Plant Science Gmbh | Expression cassettes for seed-preferential expression in plants |
EP1882037A2 (en) | 2005-05-10 | 2008-01-30 | BASF Plant Science GmbH | Expression cassettes for seed-preferential expression in plants |
DE102005022642A1 (en) * | 2005-05-11 | 2006-11-16 | Basf Ag | 2,6-naphthyl radicals containing compounds |
US8993846B2 (en) | 2005-09-06 | 2015-03-31 | Monsanto Technology Llc | Vectors and methods for improved plant transformation efficiency |
WO2007041419A1 (en) * | 2005-10-03 | 2007-04-12 | Monsanto Technology Llc | Transgenic plant seed with increased lysine |
CA2625031C (en) | 2005-10-13 | 2016-07-19 | Monsanto Technology Llc | Methods for producing hybrid seed |
WO2008034648A1 (en) | 2006-04-05 | 2008-03-27 | Metanomics Gmbh | Process for the production of a fine chemical |
US7939721B2 (en) | 2006-10-25 | 2011-05-10 | Monsanto Technology Llc | Cropping systems for managing weeds |
AU2008214568B2 (en) | 2007-02-16 | 2013-04-18 | Basf Plant Science Gmbh | Nucleic acid sequences for regulation of embryo-specific expression in monocotyledonous plants |
CN101541746B (en) * | 2007-02-20 | 2013-01-02 | 密执安州立大学董事会 | Catalytic deamination for carprolactam production |
CN105112438A (en) | 2007-03-09 | 2015-12-02 | 孟山都技术公司 | Methods for plant transformation using spectinomycin selection |
US8097712B2 (en) | 2007-11-07 | 2012-01-17 | Beelogics Inc. | Compositions for conferring tolerance to viral disease in social insects, and the use thereof |
EP2318373A1 (en) * | 2008-07-24 | 2011-05-11 | Draths Corporation | Methods of making cyclic amide monomers, and related derivatives and methods |
BRPI1006614A2 (en) | 2009-04-17 | 2015-08-25 | Basf Plant Science Co Gmbh | Isolated promoter or active fragment or derivative thereof, expression construct, expression vector, method for producing an expression construct, process for producing an expression vector, use of isolated promoter or active fragment or derivative thereof, plant or part of the transgenic plant, method of producing a transgenic plant cell, method for producing a transgenic plant or transgenic seedling, method for producing a transgenic seed from a plant, process for reproducing a transgenic plant, method for expression of a nucleic acid and method for modulating or assigning a phenotype or trait in a plant part or plant |
CA2766858A1 (en) | 2009-07-10 | 2011-01-13 | Basf Plant Science Company Gmbh | Expression cassettes for endosperm-specific expression in plants |
US8962584B2 (en) | 2009-10-14 | 2015-02-24 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Compositions for controlling Varroa mites in bees |
CA2782290A1 (en) | 2009-12-03 | 2011-06-09 | Basf Plant Science Company Gmbh | Expression cassettes for embryo-specific expression in plants |
CN102191227B (en) * | 2010-03-04 | 2013-10-09 | 中国科学院上海生命科学研究院 | Dihydrodipicolinate synthase |
ES2641642T3 (en) | 2010-03-08 | 2017-11-10 | Monsanto Technology Llc | Polynucleotide molecules for gene regulation in plants |
US9441235B2 (en) | 2010-07-23 | 2016-09-13 | Wisconsin Alumni Research Foundation | Feruloyl-CoA:monolignol transferase |
EP2675908A1 (en) * | 2011-02-14 | 2013-12-25 | Xyleco, Inc. | Processing biomass |
US10760086B2 (en) | 2011-09-13 | 2020-09-01 | Monsanto Technology Llc | Methods and compositions for weed control |
UA116089C2 (en) | 2011-09-13 | 2018-02-12 | Монсанто Текнолоджи Ллс | Methods and compositios for weed control |
AU2012308765B2 (en) | 2011-09-13 | 2018-06-21 | Monsanto Technology Llc | Methods and compositions for weed control |
PL2755467T3 (en) | 2011-09-13 | 2018-01-31 | Monsanto Technology Llc | Methods and compositions for weed control |
US10829828B2 (en) | 2011-09-13 | 2020-11-10 | Monsanto Technology Llc | Methods and compositions for weed control |
US9840715B1 (en) | 2011-09-13 | 2017-12-12 | Monsanto Technology Llc | Methods and compositions for delaying senescence and improving disease tolerance and yield in plants |
EP3434780A1 (en) | 2011-09-13 | 2019-01-30 | Monsanto Technology LLC | Methods and compositions for weed control |
US10806146B2 (en) | 2011-09-13 | 2020-10-20 | Monsanto Technology Llc | Methods and compositions for weed control |
US9920326B1 (en) | 2011-09-14 | 2018-03-20 | Monsanto Technology Llc | Methods and compositions for increasing invertase activity in plants |
CA2851231C (en) | 2011-10-06 | 2018-06-12 | Board Of Trustees Of Michigan State University | Hibiscus cannabinus feruloyl-coa:monolignol transferase |
US10428342B2 (en) | 2011-12-16 | 2019-10-01 | Board Of Trustees Of Michigan State University | P-coumaroyl-CoA:monolignol transferase |
AR091143A1 (en) | 2012-05-24 | 2015-01-14 | Seeds Ltd Ab | COMPOSITIONS AND METHODS TO SILENCE GENETIC EXPRESSION |
AR093058A1 (en) | 2012-10-18 | 2015-05-13 | Monsanto Technology Llc | METHODS AND COMPOSITIONS FOR PLANT PEST CONTROL |
BR112015015975A2 (en) | 2013-01-01 | 2018-11-06 | A. B. Seeds Ltd. | isolated dsrna molecules and methods of using them for silencing target molecules of interest. |
US10683505B2 (en) | 2013-01-01 | 2020-06-16 | Monsanto Technology Llc | Methods of introducing dsRNA to plant seeds for modulating gene expression |
US10000767B2 (en) | 2013-01-28 | 2018-06-19 | Monsanto Technology Llc | Methods and compositions for plant pest control |
CN105074008A (en) | 2013-03-13 | 2015-11-18 | 孟山都技术有限公司 | Methods and compositions for weed control |
US10612019B2 (en) | 2013-03-13 | 2020-04-07 | Monsanto Technology Llc | Methods and compositions for weed control |
US20140283211A1 (en) | 2013-03-14 | 2014-09-18 | Monsanto Technology Llc | Methods and Compositions for Plant Pest Control |
US10568328B2 (en) | 2013-03-15 | 2020-02-25 | Monsanto Technology Llc | Methods and compositions for weed control |
CN105980567B (en) | 2013-07-19 | 2021-04-16 | 孟山都技术有限公司 | Compositions and methods for controlling phyllometaca |
US9850496B2 (en) | 2013-07-19 | 2017-12-26 | Monsanto Technology Llc | Compositions and methods for controlling Leptinotarsa |
JP6110273B2 (en) * | 2013-10-22 | 2017-04-05 | 株式会社泰陽貿易 | Imitation paper money and its manufacturing method |
AU2014341879B2 (en) | 2013-11-04 | 2020-07-23 | Beeologics, Inc. | Compositions and methods for controlling arthropod parasite and pest infestations |
UA119253C2 (en) | 2013-12-10 | 2019-05-27 | Біолоджикс, Інк. | Compositions and methods for virus control in varroa mite and bees |
MX368629B (en) | 2014-01-15 | 2019-10-08 | Monsanto Technology Llc | Methods and compositions for weed control using epsps polynucleotides. |
US11091770B2 (en) | 2014-04-01 | 2021-08-17 | Monsanto Technology Llc | Compositions and methods for controlling insect pests |
CN106795515B (en) | 2014-06-23 | 2021-06-08 | 孟山都技术公司 | Compositions and methods for modulating gene expression via RNA interference |
EP3161138A4 (en) | 2014-06-25 | 2017-12-06 | Monsanto Technology LLC | Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression |
EP3174982A4 (en) | 2014-07-29 | 2018-06-20 | Monsanto Technology LLC | Compositions and methods for controlling insect pests |
PL3256589T3 (en) | 2015-01-22 | 2022-02-21 | Monsanto Technology Llc | Compositions and methods for controlling leptinotarsa |
AU2016270870A1 (en) | 2015-06-02 | 2018-01-04 | Monsanto Technology Llc | Compositions and methods for delivery of a polynucleotide into a plant |
EP3302030A4 (en) | 2015-06-03 | 2019-04-24 | Monsanto Technology LLC | Methods and compositions for introducing nucleic acids into plants |
WO2017132330A1 (en) | 2016-01-26 | 2017-08-03 | Monsanto Technology Llc | Compositions and methods for controlling insect pests |
US10858687B2 (en) | 2017-02-13 | 2020-12-08 | Board Of Trustees Of Michigan State University | Lipid biosynthesis and abiotic stress resilience in photosynthetic organisms |
US10822583B2 (en) | 2017-02-13 | 2020-11-03 | Board Of Trustees Of Michigan State University | Lipid biosynthesis and abiotic stress resilience in photosynthetic organisms |
US10883089B2 (en) | 2017-04-04 | 2021-01-05 | Wisconsin Alumni Research Foundation | Feruloyl-CoA:monolignol transferases |
US10883090B2 (en) | 2017-04-18 | 2021-01-05 | Wisconsin Alumni Research Foundation | P-coumaroyl-CoA:monolignol transferases |
BR112021007864A2 (en) | 2018-11-09 | 2021-08-10 | Wisconsin Alumni Research Foundation | recombinant nucleic acid, methods and fertile transgenic plant |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE240792C (en) * | ||||
JPS5618596A (en) * | 1979-07-23 | 1981-02-21 | Ajinomoto Co Inc | Production of l-lysine through fermentation process |
JPS56160997A (en) * | 1980-05-16 | 1981-12-11 | Ajinomoto Co Inc | Preparation of l-lysine by fermenaition method |
US4535060A (en) * | 1983-01-05 | 1985-08-13 | Calgene, Inc. | Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthetase, production and use |
US4642411A (en) * | 1984-09-04 | 1987-02-10 | Molecular Genetics Research And Development Limited Partnership | Tryptophan overproducer mutants of cereal crops |
ATE93542T1 (en) * | 1984-12-28 | 1993-09-15 | Plant Genetic Systems Nv | RECOMBINANT DNA THAT CAN BE INTRODUCED INTO PLANT CELLS. |
AU590597B2 (en) * | 1985-08-07 | 1989-11-09 | Monsanto Technology Llc | Glyphosate-resistant plants |
JPH0795952B2 (en) * | 1986-01-08 | 1995-10-18 | カルジ−ン・インコ−ポレイテツド | Haloaryl nitrile degrading gene, its use and cells containing said gene |
JPS63192383A (en) * | 1986-12-08 | 1988-08-09 | サンジェン・テクノロジーズ・コーポレイション | Method for increasing free pool lisine content in corn |
-
1988
- 1988-06-09 US US07/204,388 patent/US5258300A/en not_active Expired - Lifetime
-
1989
- 1989-03-28 CA CA000594827A patent/CA1338349C/en not_active Expired - Lifetime
- 1989-03-29 AU AU35402/89A patent/AU3540289A/en not_active Abandoned
- 1989-03-29 WO PCT/US1989/001309 patent/WO1989011789A1/en active IP Right Grant
- 1989-03-29 EP EP89905254A patent/EP0429458B1/en not_active Expired - Lifetime
- 1989-03-29 RO RO146495A patent/RO111473B1/en unknown
- 1989-03-29 JP JP01504994A patent/JP3083531B2/en not_active Expired - Lifetime
- 1989-03-29 DE DE68912783T patent/DE68912783T2/en not_active Expired - Lifetime
- 1989-03-29 HU HU892853A patent/HU214630B/en unknown
- 1989-03-31 CN CN89103204.5A patent/CN1045995C/en not_active Expired - Lifetime
- 1989-03-31 AR AR89313554A patent/AR243236A1/en active
Non-Patent Citations (3)
Title |
---|
FEBS LETTERS, vol. 116, no. 2, July 1980, pages 189-192, Elsevier/North-Holland Biomedical Press; R.M. WALLSGROVE et al.: "The enzymology of lysine biosynthesis in higher plants" * |
MEDEC. FAC. LANDBOUWWET, RIJKSUNIV. GENT, vol. 52, no. 4B, 1987, pages 1835-1842; W. GHISLAIN et al.: "Cloning procedures of a lysine overproduction determininggene from Nicotiana sylvestris" * |
See also references of WO8911789A1 * |
Also Published As
Publication number | Publication date |
---|---|
DE68912783D1 (en) | 1994-03-10 |
HU214630B (en) | 1998-08-28 |
AU3540289A (en) | 1990-01-05 |
RO111473B1 (en) | 1996-10-31 |
EP0429458A1 (en) | 1991-06-05 |
WO1989011789A1 (en) | 1989-12-14 |
CA1338349C (en) | 1996-05-28 |
US5258300A (en) | 1993-11-02 |
AR243236A1 (en) | 1993-07-30 |
JPH03504798A (en) | 1991-10-24 |
CN1038465A (en) | 1990-01-03 |
EP0429458B1 (en) | 1994-01-26 |
JP3083531B2 (en) | 2000-09-04 |
DE68912783T2 (en) | 1994-05-19 |
CN1045995C (en) | 1999-10-27 |
HUT56137A (en) | 1991-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5258300A (en) | Method of inducing lysine overproduction in plants | |
US5545545A (en) | Lysine-insensitive maize dihydrodipicolinic acid synthase | |
US6271016B1 (en) | Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction | |
AU724041B2 (en) | Production of water stress or salt stress tolerant transgenic cereal plants | |
CA2280196C (en) | Chimeric genes and methods for increasing the lysine content of the seeds of plants | |
CA2177351C (en) | Chimeric genes and methods for increasing the lysine content of the seeds of corn, soybean and rapeseed plants | |
WO1997026366A9 (en) | Anthranilate synthase gene and use thereof | |
WO1997013843A9 (en) | Production of water stress or salt stress tolerant transgenic cereal plants | |
WO1998013506A1 (en) | Binary methods of increasing accumulation of essential amino acids in seeds | |
EP0200746B1 (en) | Plant cells resistant to herbicidal glutamine synthetase inhibitors | |
WO1987005327A1 (en) | Plant cells resistant to herbicidal glutamine synthetase inhibitors | |
CA1341452C (en) | Method of inducing lysine overproduction in plants | |
Pilacinski et al. | 11 Patent Number:(45) Date of Patent | |
US20050005330A1 (en) | Chimeric genes and methods for increasing the lysine content of the seeds of plants | |
AU609391C (en) | Plant cells resistant to herbicidal glutamine synthetase inhibitors | |
Shaver | Molecular analysis of transgenic maize modified for increased lysine biosynthesis | |
MXPA00007707A (en) | Alteration of amino acid compositions in seeds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19901201 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE FR IT NL |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19910916 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): DE FR IT NL |
|
17Q | First examination report despatched |
Effective date: 19930422 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): DE FR IT NL |
|
REF | Corresponds to: |
Ref document number: 68912783 Country of ref document: DE Date of ref document: 19940310 |
|
ITF | It: translation for a ep patent filed | ||
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20080324 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20080430 Year of fee payment: 20 Ref country code: FR Payment date: 20080317 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20080329 Year of fee payment: 20 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20090329 |
|
NLV7 | Nl: ceased due to reaching the maximum lifetime of a patent |
Effective date: 20090329 |